iconstar paper   Hepatitis C Articles (HCV)  
Back grey arrow rt.gif
Patient Advocate Foundation Announces Co-Pay Relief (CPR) Support for Patients Living with Hepatitis C
  From Jules: both Gilead & J&J also have their own co-pay & Patient Assistance Programs:
Sofosbuvir (Sovaldi) - Gilead U.S. Patient Assistance Program
Simeprevir (Olysio) J & J Patient Access Programs
HAMPTON, Va., Feb. 5, 2014
The launch of the CPR Silo for Hepatitis C Patients Will Provide Financial Assistance to Patients in Need
HAMPTON, Va., Feb. 5, 2014 /PRNewswire-USNewswire/ -- Patient Advocate Foundation (PAF) announced today the expansion of its Co-Pay Relief (CPR) program with the opening of the Hepatitis C disease silo. Supported through a generous donation of 5 million dollars, this CPR program silo providers financial support for pharmaceutical co-payments for insured patients who are facing financial distress and are unable to afford their costs associated with treatment for the virus. "Management of Hepatitis C is extremely challenging for patients as most need ongoing medication to reduce their chance of liver damage or liver cancer. It is in these cases that a patient's survival and overall health can be jeopardized if he or she is unable to access pharmaceutical treatment and therapies required to control the virus," said Alan Balch, PhD, CEO of PAF. "We are grateful for the significant support we have received for the Hepatitis C silo which allows us to expand our Co-Pay Relief Program in such a meaningful way." The donation allows PAF to provide financial support to Hepatitis C patients ensuring their access to the treatments that can restore balance to their health and markedly improve their quality of life. Qualified patients whose applications are approved, are eligible for up to $3,000 per year in copayment assistance through the program.
PAF is a pioneer in the field of copayment support programs, providing more than $190 million in financial assistance to more than 95,000 patients who would have been otherwise unable to afford their pharmaceutical co-payments since 2004. The program provides this support to insured patients who financially and medically qualify including those covered by government sponsored insurance programs such as Medicare, Medicaid or Tricare.
For more information about PAF's Co-Pay Relief program and the options for assistance for Hepatitis C patients, visit http://www.copays.org/diseases/hepatitis-c or call 866-512-3861.
About the Patient Advocate Foundation (PAF) Co-Pay Relief Program (CPR)
The Co-Pay Relief Program, a division of Patient Advocate Foundation, provides direct financial support for pharmaceutical co-payments to insured patients who financially and medically qualify.
The program offers innovative technology tools for patients, providers and pharmacy representatives including 24 hour web based application portals, electronic signature, document upload and bar code fax routing capabilities, increasing the speed with which an approval can be granted and expenditure can be paid. Keeping with Patient Advocate Foundation's emphasis on patient-centric service, the program also offers individualized assistance to all patients through trained, professional staff who personally guide them through the enrollment process.
For more information or to contact Patient Advocate Foundation's Co-Pay Relief program visit www.copays.org or 1-866-512-3861

  iconpaperstack View Older Articles   Back to Top   www.natap.org